PP-PFE-GBR-2272. January 2020

You must or to place an order.

Download and / or order the materials of your choice. There are no costs involved.

Select the quantity of the material you want to order and click 'Add to cart'

Alternatively click 'Download' to immediately download you selected material

When you have finished, click 'Place Order' within your cart

Filter search results

Image of ACRODAT HCP information

Somavert (pegvisomant) ACRODAT HCP information

Find information on the development of the ACRODAT patient monitoring tool, adding and evaluating patients and visit data.

Somavert prescribing information can be found here.

PP-RDP-GBR-0405. May 2020

Image of acromegaly patient and HCP guide to prescribing treatment

Somavert (pegvisomant) HCP Prescribing Guide

Find information on funding, initiation, homecare and follow-up.

Somavert prescribing information can be found here.

PP-RDP-GBR-0403. May 2020

Therapy Management Guide

SUTENT® (sunitinib malate) Therapy Management Guide

A guide to managing a selection of common adverse events associated with Sutent in the treatment of advanced/metastatic renal cell carcinoma. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent. 

PP-SUT-GBR-0646. September 2020

Start;Smart;Focus;Poster

Start Smart then Focus Poster

One page poster overview of the Start Smart then Focus Public Health England antimicrobial prescribing guidance.

Ask Pfizer: If you would like to receive further information about these materials or our work to support AMS, please contact your local Pfizer Account Manager here

PP-AIP-GBR-0271. January 2020

NICE;Guidance Summary

NICE Guidance Summary

NICE Guidance Summary.

Ask Pfizer: If you would like to receive further information about these materials or our work to support AMS, please contact your local Pfizer Account Manager here.

PP-AIP-GBR-0276. January 2020

AMS Lead Guide

AMS Lead Guide

Guide for a clinical lead to implement an antimicrobial stewardship programme in their clinical setting. Leading an AMS programme is a multi-faceted process requiring a coordinated response that engages colleagues and supports their active involvement. The items within this pack are designed to help you and your AMS Champions deliver enhanced and consistent patient care through collaboration between all members of the hospital team.

Ask Pfizer: If you would like to receive further information about these materials or our work to support AMS, please contact your local Pfizer Account Manager here.

PP-AIP-GBR-0270. January 2020

Antimicrobial Awareness Poster

AMS Awareness Poster

AMS poster to help raise awareness of antimicrobial stewardship initiatives with clinical staff in a secondary care setting.

Ask Pfizer: If you would like to receive further information about these materials or our work to support AMS, please contact your local Pfizer Account Manager here.

PP-AIP-GBR-0274. January 2020

AMS Champions Starter Pack

AMS Champions Starter Pack

Overview of the contents in the AMS Champions Starter Pack, designed to support hospital staff in their role as Champions for antimicrobial stewardship. As an AMS Champion you play a key role in engaging with colleagues and supporting their active involvement with antimicrobial stewardship. The items within this pack are designed to help AMS Champions deliver enhanced and consistent patient care through collaboration with all members of the hospital team.

Ask Pfizer: If you would like to receive further information about these materials or our work to support AMS, please contact your local Pfizer Account Manager here.

PP-AIP-GBR-0273. January 2020

AMS Champions Folder

AMS Champions Folder

A4 printed folder to hold Antimicrobial Stewardship Champions Starter Pack.

Ask Pfizer: If you would like to receive further information about these materials or our work to support AMS, please contact your local Pfizer Account Manager here.

PP-AIP-GBR-0272. January 2020

AMS Lead Starter Pack

AMS Lead Starter Pack

Guide providing an introductory overview of the purpose and contents of the AMS "We all have our part to play" Resources. This piece supports a clinical lead to implement an antimicrobial stewardship programme within their clinical setting and details the key steps required to implement or extend an antimicrobial stewardship programme.

Ask Pfizer: If you would like to receive further information about these materials or our work to support AMS, please contact your local Pfizer Account Manager here.

PP-AIP-GBR-0275. January 2020

Inlyta® (axitinib) Patient Treatment Information Brochure

This booklet is for patients prescribed Inlyta for advanced renal cell carcinoma (aRCC). It contains information about Inlyta, general advice on managing side effects, definition of relevant clinical terms as well as a diary and notes section. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Inlyta.  

PP-INL-GBR-0791. September 2020

SUTENT® (sunitinib malate) pNET Patient Treatment Diary

A diary to help patients with pancreatic neuroendocrine tumours (pNET) note appointments, questions, concerns and side effects related to their Sutent treatment. Click 'Download' to browse the content and if this is of interest,   please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0640. September 2020

SUTENT® (sunitinib malate) ASSIST Carers' Information Brochure

This brochure offers guidance and support for people caring for patients prescribed Sutent for the treatment of advanced/metastatic renal cell carcinoma. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.  

PP-SUT-GBR-0644. September 2020

Inlyta® (axitinib) Blood Pressure Monitoring Booklet for Patients

This booklet helps patients prescribed Inlyta for advanced renal cell carcinoma (aRCC) understand blood pressure, how to measure it and provides a diary section to aid blood pressure tracking for 38 weeks. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Inlyta.  

PP-INL-GBR-0792. September 2020

SUTENT® (sunitinib malate) ASSIST Patient Treatment Diary

A diary to help patients with advanced/metastatic renal cell carcinoma note appointments, questions, concerns and side effects related to their Sutent treatment. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0645. September 2020

SUTENT® (sunitinib malate) ASSIST Patient Treatment Booklet

This booklet offers guidance and support to patients prescribed Sutent for advanced/metastatic renal cell carcinoma. It helps them understand their condition, treatment and also includes tips to manage side effects. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0643. September 2020

SUTENT® (sunitinib malate) pNET Patient Booklet

This booklet offers guidance and support to patients prescribed Sutent for pancreatic neuroendocrine tumours (pNET). It helps them understand their condition, treatment and also includes tips to manage side effects. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0642. September 2020

SUTENT® (sunitinib malate) GIST Patient Brochure

This booklet offers guidance and support to patients prescribed Sutent for gastrointestinal stromal tumour (GIST). It helps them understand their condition, treatment and also includes tips to manage side effects. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0641. September 2020

SUTENT® (sunitinib malate) GIST Patient Diary

A diary to help patients with gastrointestinal stromal tumour (GIST) note appointments, questions, concerns and side effects related to their Sutent treatment. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0639. September 2020

SUTENT® (sunitinib malate) Treatment Tracker

A treatment tracker chart for patients on Sutent to help them remember to take their treatment as prescribed. Click 'Download' to browse the content and if this is of interest,  please visit Medisa to request printed materials.

Click here for Prescribing and Adverse Event Reporting Information for Sutent.

PP-SUT-GBR-0638. September 2020